Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users

Documenti analoghi

• Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
  di: Laliberté, François, et al.
  Pubblicazione: (2015)
• Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users
  di: Olson, William H., et al.
  Pubblicazione: (2015)
• Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
  di: Colleen A McHorney, et al.
  Pubblicazione: (2018-01-01)
• Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
  di: McHorney, Colleen A., et al.
  Pubblicazione: (2018)
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
  Pubblicazione: (2012)